| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Out-of-Hospital Cardiac Arrest | 8 | 2025 | 56 | 3.970 |
Why?
|
| Ultrasonography | 23 | 2022 | 486 | 3.480 |
Why?
|
| Abscess | 7 | 2021 | 80 | 3.090 |
Why?
|
| Point-of-Care Systems | 11 | 2022 | 132 | 2.840 |
Why?
|
| Emergency Medicine | 10 | 2021 | 193 | 2.500 |
Why?
|
| Heart Arrest | 5 | 2023 | 177 | 2.220 |
Why?
|
| Echocardiography | 7 | 2025 | 509 | 2.020 |
Why?
|
| Cardiopulmonary Resuscitation | 5 | 2025 | 94 | 1.840 |
Why?
|
| Drainage | 6 | 2021 | 155 | 1.770 |
Why?
|
| Advanced Cardiac Life Support | 3 | 2022 | 16 | 1.220 |
Why?
|
| Respiratory Insufficiency | 5 | 2013 | 154 | 1.180 |
Why?
|
| Dichlorvos | 5 | 2013 | 15 | 1.140 |
Why?
|
| Organophosphate Poisoning | 4 | 2013 | 14 | 1.120 |
Why?
|
| Fellowships and Scholarships | 3 | 2021 | 107 | 1.110 |
Why?
|
| Ultrasonography, Interventional | 4 | 2017 | 116 | 1.080 |
Why?
|
| Soft Tissue Infections | 3 | 2017 | 48 | 1.040 |
Why?
|
| Prospective Studies | 18 | 2025 | 3315 | 0.990 |
Why?
|
| Apnea | 3 | 2013 | 32 | 0.850 |
Why?
|
| Ventricular Fibrillation | 1 | 2025 | 107 | 0.850 |
Why?
|
| Hepatectomy | 1 | 2024 | 64 | 0.820 |
Why?
|
| Respiratory Center | 2 | 2013 | 3 | 0.810 |
Why?
|
| Emergency Service, Hospital | 8 | 2025 | 1118 | 0.780 |
Why?
|
| Staphylococcal Skin Infections | 2 | 2014 | 13 | 0.760 |
Why?
|
| Education, Medical, Graduate | 5 | 2016 | 350 | 0.750 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2014 | 66 | 0.720 |
Why?
|
| Adrenergic Agents | 2 | 2018 | 15 | 0.680 |
Why?
|
| Clinical Competence | 6 | 2015 | 728 | 0.680 |
Why?
|
| Humans | 48 | 2025 | 64243 | 0.660 |
Why?
|
| Rats, Wistar | 11 | 2014 | 187 | 0.650 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2013 | 46 | 0.650 |
Why?
|
| Physical Examination | 2 | 2018 | 111 | 0.610 |
Why?
|
| Treatment Failure | 6 | 2021 | 200 | 0.610 |
Why?
|
| Liver | 1 | 2024 | 868 | 0.600 |
Why?
|
| Male | 30 | 2025 | 30295 | 0.590 |
Why?
|
| Liver Transplantation | 4 | 2022 | 217 | 0.540 |
Why?
|
| Internship and Residency | 6 | 2015 | 808 | 0.540 |
Why?
|
| Regional Blood Flow | 2 | 2014 | 110 | 0.510 |
Why?
|
| Pulmonary Gas Exchange | 2 | 2014 | 43 | 0.480 |
Why?
|
| Organophosphates | 2 | 2013 | 16 | 0.480 |
Why?
|
| Retrospective Studies | 9 | 2025 | 6726 | 0.460 |
Why?
|
| Insecticides | 3 | 2012 | 45 | 0.450 |
Why?
|
| Learning Curve | 1 | 2015 | 34 | 0.450 |
Why?
|
| Hypoxia | 2 | 2014 | 116 | 0.450 |
Why?
|
| Adult | 19 | 2024 | 17117 | 0.440 |
Why?
|
| Rats | 10 | 2013 | 2005 | 0.430 |
Why?
|
| Atropine | 1 | 2014 | 13 | 0.420 |
Why?
|
| Decision Trees | 1 | 2014 | 50 | 0.420 |
Why?
|
| Dehydration | 1 | 2014 | 17 | 0.420 |
Why?
|
| Pulmonary Ventilation | 1 | 2014 | 38 | 0.420 |
Why?
|
| Blood Volume | 1 | 2014 | 40 | 0.420 |
Why?
|
| Female | 22 | 2025 | 33351 | 0.420 |
Why?
|
| Carotid Arteries | 1 | 2014 | 61 | 0.410 |
Why?
|
| Certification | 1 | 2014 | 57 | 0.410 |
Why?
|
| Fluid Therapy | 1 | 2014 | 46 | 0.410 |
Why?
|
| Bronchodilator Agents | 1 | 2014 | 119 | 0.390 |
Why?
|
| Sensitivity and Specificity | 6 | 2016 | 1162 | 0.380 |
Why?
|
| Middle Aged | 12 | 2025 | 17899 | 0.380 |
Why?
|
| Aged | 9 | 2025 | 14648 | 0.380 |
Why?
|
| Point-of-Care Testing | 2 | 2022 | 42 | 0.370 |
Why?
|
| Parathion | 1 | 2012 | 5 | 0.370 |
Why?
|
| Soybean Oil | 1 | 2012 | 32 | 0.370 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2012 | 37 | 0.360 |
Why?
|
| Phospholipids | 1 | 2012 | 82 | 0.360 |
Why?
|
| Lung | 3 | 2022 | 964 | 0.360 |
Why?
|
| Brain Stem | 1 | 2011 | 28 | 0.340 |
Why?
|
| Sleep Apnea, Central | 1 | 2011 | 8 | 0.340 |
Why?
|
| Radiology | 1 | 2015 | 257 | 0.330 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2011 | 67 | 0.330 |
Why?
|
| Electrocardiography | 2 | 2025 | 554 | 0.330 |
Why?
|
| Anti-Bacterial Agents | 2 | 2006 | 800 | 0.310 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2009 | 27 | 0.300 |
Why?
|
| Abdomen | 2 | 2006 | 93 | 0.300 |
Why?
|
| Vagotomy | 1 | 2009 | 6 | 0.300 |
Why?
|
| Sorption Detoxification | 1 | 2009 | 1 | 0.300 |
Why?
|
| United States | 8 | 2021 | 7923 | 0.290 |
Why?
|
| Vena Cava, Inferior | 1 | 2009 | 32 | 0.290 |
Why?
|
| Skin Diseases | 1 | 2009 | 83 | 0.280 |
Why?
|
| Gallbladder Diseases | 1 | 2008 | 27 | 0.280 |
Why?
|
| Acute Disease | 4 | 2013 | 672 | 0.280 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 104 | 0.260 |
Why?
|
| Ludwig's Angina | 1 | 2006 | 1 | 0.250 |
Why?
|
| Infant | 4 | 2017 | 1664 | 0.250 |
Why?
|
| Radiography, Abdominal | 1 | 2006 | 26 | 0.250 |
Why?
|
| Pesticides | 1 | 2007 | 56 | 0.240 |
Why?
|
| Child, Preschool | 4 | 2017 | 2018 | 0.240 |
Why?
|
| Flank Pain | 1 | 2005 | 8 | 0.240 |
Why?
|
| Cystitis | 1 | 2005 | 10 | 0.240 |
Why?
|
| Staphylococcus | 1 | 2005 | 17 | 0.240 |
Why?
|
| Gram-Negative Bacteria | 1 | 2005 | 56 | 0.230 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2006 | 58 | 0.230 |
Why?
|
| Urinary Tract Infections | 1 | 2006 | 93 | 0.220 |
Why?
|
| Animals | 12 | 2014 | 20962 | 0.220 |
Why?
|
| Drug Resistance | 1 | 2005 | 155 | 0.220 |
Why?
|
| Kidney Diseases | 1 | 2005 | 180 | 0.210 |
Why?
|
| Lactic Acid | 1 | 2024 | 75 | 0.200 |
Why?
|
| Central Nervous System Depressants | 1 | 2024 | 46 | 0.200 |
Why?
|
| Ketamine | 1 | 2024 | 38 | 0.200 |
Why?
|
| Reoperation | 2 | 2018 | 291 | 0.200 |
Why?
|
| Ultrasonography, Doppler | 1 | 2023 | 27 | 0.200 |
Why?
|
| Societies, Medical | 2 | 2016 | 381 | 0.190 |
Why?
|
| Child | 5 | 2017 | 4583 | 0.190 |
Why?
|
| Incidence | 2 | 2025 | 1383 | 0.190 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2024 | 145 | 0.180 |
Why?
|
| Drug Overdose | 1 | 2024 | 122 | 0.180 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 5520 | 0.180 |
Why?
|
| Adolescent | 5 | 2017 | 6304 | 0.170 |
Why?
|
| Data Collection | 1 | 2023 | 384 | 0.170 |
Why?
|
| Young Adult | 3 | 2018 | 4776 | 0.170 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2021 | 41 | 0.170 |
Why?
|
| Escherichia coli | 1 | 2006 | 718 | 0.170 |
Why?
|
| Magnetics | 1 | 2001 | 53 | 0.170 |
Why?
|
| Respiration | 2 | 2013 | 92 | 0.170 |
Why?
|
| Electric Countershock | 1 | 2021 | 103 | 0.170 |
Why?
|
| Heart Failure | 1 | 2009 | 926 | 0.170 |
Why?
|
| Prognosis | 1 | 2025 | 1769 | 0.170 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 2737 | 0.160 |
Why?
|
| Benchmarking | 1 | 2021 | 134 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2022 | 5691 | 0.160 |
Why?
|
| Tissue Donors | 3 | 2022 | 154 | 0.160 |
Why?
|
| Pilot Projects | 2 | 2014 | 1019 | 0.160 |
Why?
|
| Faculty, Medical | 1 | 2021 | 200 | 0.150 |
Why?
|
| Organophosphorus Compounds | 2 | 2013 | 32 | 0.150 |
Why?
|
| Heart Rate | 2 | 2014 | 327 | 0.150 |
Why?
|
| Time Factors | 4 | 2016 | 3724 | 0.150 |
Why?
|
| Intubation, Intratracheal | 1 | 2001 | 203 | 0.150 |
Why?
|
| Telemedicine | 1 | 2024 | 344 | 0.140 |
Why?
|
| Curriculum | 2 | 2015 | 606 | 0.140 |
Why?
|
| Blood Pressure | 2 | 2014 | 517 | 0.140 |
Why?
|
| Disease Models, Animal | 5 | 2013 | 2238 | 0.140 |
Why?
|
| Epinephrine | 1 | 2017 | 47 | 0.130 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 65 | 0.130 |
Why?
|
| Postoperative Complications | 1 | 2024 | 1294 | 0.130 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 1681 | 0.130 |
Why?
|
| Risk Factors | 2 | 2024 | 5339 | 0.120 |
Why?
|
| Survival Analysis | 2 | 2016 | 587 | 0.120 |
Why?
|
| Canada | 1 | 2016 | 151 | 0.120 |
Why?
|
| Pneumothorax | 1 | 2016 | 50 | 0.120 |
Why?
|
| Confidence Intervals | 2 | 2014 | 239 | 0.120 |
Why?
|
| Alagille Syndrome | 1 | 2015 | 2 | 0.120 |
Why?
|
| Liver Failure, Acute | 1 | 2015 | 26 | 0.120 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 156 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 214 | 0.100 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 412 | 0.100 |
Why?
|
| Registries | 1 | 2017 | 885 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2015 | 219 | 0.100 |
Why?
|
| Community-Acquired Infections | 1 | 2014 | 94 | 0.100 |
Why?
|
| Echocardiography, Doppler | 1 | 2014 | 133 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2006 | 984 | 0.100 |
Why?
|
| Diphenhydramine | 2 | 2003 | 9 | 0.100 |
Why?
|
| Histamine H1 Antagonists | 2 | 2003 | 10 | 0.100 |
Why?
|
| Nerve Net | 1 | 2013 | 99 | 0.090 |
Why?
|
| Respiratory Mechanics | 1 | 2012 | 56 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2013 | 607 | 0.090 |
Why?
|
| Hemodynamics | 1 | 2013 | 249 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2006 | 2478 | 0.090 |
Why?
|
| ROC Curve | 1 | 2012 | 288 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 869 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2006 | 1375 | 0.090 |
Why?
|
| Microdialysis | 1 | 2011 | 5 | 0.090 |
Why?
|
| Respiratory Rate | 1 | 2011 | 15 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2012 | 374 | 0.080 |
Why?
|
| Tidal Volume | 1 | 2011 | 41 | 0.080 |
Why?
|
| Jugular Veins | 1 | 2010 | 29 | 0.080 |
Why?
|
| Logistic Models | 1 | 2014 | 1270 | 0.080 |
Why?
|
| Oxygen | 1 | 2012 | 321 | 0.080 |
Why?
|
| Methyl Parathion | 1 | 2010 | 3 | 0.080 |
Why?
|
| Models, Anatomic | 1 | 2010 | 63 | 0.080 |
Why?
|
| Aryldialkylphosphatase | 1 | 2010 | 19 | 0.080 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 1990 | 5 | 0.080 |
Why?
|
| Critical Care | 1 | 2014 | 403 | 0.080 |
Why?
|
| Abdominal Injuries | 1 | 2010 | 33 | 0.080 |
Why?
|
| Catheterization, Central Venous | 1 | 2010 | 83 | 0.080 |
Why?
|
| Competency-Based Education | 1 | 2009 | 30 | 0.080 |
Why?
|
| Subcutaneous Tissue | 1 | 2009 | 14 | 0.080 |
Why?
|
| Cellulitis | 1 | 2009 | 22 | 0.080 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2009 | 35 | 0.070 |
Why?
|
| Hemochromatosis | 1 | 2009 | 7 | 0.070 |
Why?
|
| Budd-Chiari Syndrome | 1 | 2009 | 5 | 0.070 |
Why?
|
| Employment | 1 | 2010 | 128 | 0.070 |
Why?
|
| Liver Function Tests | 1 | 2009 | 40 | 0.070 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2009 | 19 | 0.070 |
Why?
|
| Vagus Nerve | 1 | 2009 | 21 | 0.070 |
Why?
|
| Kidney Function Tests | 1 | 2009 | 37 | 0.070 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 117 | 0.070 |
Why?
|
| Emulsions | 1 | 2012 | 486 | 0.070 |
Why?
|
| Massachusetts | 1 | 2014 | 2094 | 0.070 |
Why?
|
| Optic Nerve | 1 | 2008 | 25 | 0.070 |
Why?
|
| Dyspnea | 1 | 2009 | 124 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 726 | 0.070 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2007 | 24 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 2009 | 195 | 0.070 |
Why?
|
| Catecholamines | 1 | 2007 | 31 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 1990 | 329 | 0.060 |
Why?
|
| Anesthesia, Inhalation | 1 | 2007 | 14 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 1669 | 0.060 |
Why?
|
| Blood Gas Analysis | 1 | 2007 | 35 | 0.060 |
Why?
|
| Periodontal Abscess | 1 | 2006 | 1 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2009 | 181 | 0.060 |
Why?
|
| Anesthesia, General | 1 | 2007 | 46 | 0.060 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 86 | 0.060 |
Why?
|
| Imino Acids | 1 | 2006 | 4 | 0.060 |
Why?
|
| Utilization Review | 1 | 2006 | 32 | 0.060 |
Why?
|
| Gallstones | 1 | 2006 | 25 | 0.060 |
Why?
|
| Videotape Recording | 1 | 2006 | 46 | 0.060 |
Why?
|
| Shock, Septic | 1 | 2007 | 85 | 0.060 |
Why?
|
| Cholecystitis | 1 | 2006 | 29 | 0.060 |
Why?
|
| Patient Selection | 1 | 2009 | 487 | 0.060 |
Why?
|
| Skin | 1 | 2009 | 385 | 0.060 |
Why?
|
| Medical Staff, Hospital | 1 | 2006 | 59 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 194 | 0.060 |
Why?
|
| Colic | 1 | 2005 | 2 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 306 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2006 | 96 | 0.060 |
Why?
|
| Hematuria | 1 | 2005 | 23 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2007 | 181 | 0.060 |
Why?
|
| Radiography | 1 | 2006 | 552 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 296 | 0.050 |
Why?
|
| Diazepam | 1 | 2003 | 11 | 0.050 |
Why?
|
| Muscle Relaxants, Central | 1 | 2003 | 12 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2006 | 267 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2005 | 317 | 0.050 |
Why?
|
| Glycopyrrolate | 1 | 2003 | 23 | 0.050 |
Why?
|
| Muscarinic Antagonists | 1 | 2003 | 33 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 2003 | 58 | 0.050 |
Why?
|
| Algorithms | 1 | 2007 | 1028 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2006 | 708 | 0.040 |
Why?
|
| Equipment Design | 1 | 2001 | 361 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 271 | 0.040 |
Why?
|
| Disease Progression | 1 | 2024 | 1176 | 0.040 |
Why?
|
| Lung Injury | 1 | 2016 | 36 | 0.030 |
Why?
|
| Random Allocation | 2 | 2003 | 201 | 0.020 |
Why?
|
| Carotid Artery Injuries | 1 | 2010 | 12 | 0.020 |
Why?
|
| Manikins | 1 | 2010 | 21 | 0.020 |
Why?
|
| Lethal Dose 50 | 1 | 2010 | 16 | 0.020 |
Why?
|
| Punctures | 1 | 2010 | 63 | 0.020 |
Why?
|
| Half-Life | 1 | 2010 | 79 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2010 | 71 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2010 | 106 | 0.020 |
Why?
|
| Job Satisfaction | 1 | 2010 | 141 | 0.020 |
Why?
|
| Hematemesis | 1 | 2007 | 6 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2007 | 70 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2007 | 103 | 0.020 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2007 | 74 | 0.020 |
Why?
|
| Physicians | 1 | 2010 | 483 | 0.010 |
Why?
|
| Pneumonia | 1 | 2007 | 291 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 2604 | 0.010 |
Why?
|
| Ipratropium | 1 | 2003 | 7 | 0.010 |
Why?
|
| Cholinergic Antagonists | 1 | 2003 | 32 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2004 | 498 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 240 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 1102 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2004 | 856 | 0.010 |
Why?
|
| Age Factors | 1 | 2004 | 1569 | 0.010 |
Why?
|